Tolterodine
Detrol, Detrol LA
Cholinergic Muscarinic Antagonist
NADAC/unit
$0.2057
No Shortage
Tier 1: 75.4%
PA Req: 2.4%
12 Manufacturers
26 ANDAs
Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see Clinical Studies (14) ] .
vs. brand Detrol: Generic saves up to 98% per unit
Market Intelligence
2025-04-09 Class III Recall: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Generic Manufacturers
AJANTA PHARMA LTDHETERO LABS LTD UNIT IIIHETERO LABS LTD UNIT VINVENTIA HEALTHCARE PRIVATE LTDIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USAMACLEODS PHARMACEUTICALS LTDPTS CONSULTING LLCRISING PHARMA HOLDINGS INCTEVA PHARMACEUTICALS USATORRENT PHARMACEUTICALS LTDUNICHEM LABORATORIES LTDUPJOHN US 2 LLCUTOPIC PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.